Topics

A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women

2016-03-22 06:23:23 | BioPortfolio

Summary

Iron is one of the most vital elements in humans as it plays a role in physiological functions such as transferring and storing oxygen, transporting electrons and catalysing numerous reactions, from oxidative metabolism to cellular proliferation. Iron deficiency can be attributed to poor absorption that leads to insufficient iron to meet body requirements. Oral iron supplements have been extensively used to treat iron deficiency and iron deficiency anaemia. However, the use of iron compounds in fortifying foods is one of the best practical approach to combat iron deficiency, while improving diet and food pattern involves long-term goal which can be challenging. Vitamin D has recently been shown to affect hepcidin levels, which in turn has effects on iron status but there are a limited number of studies investigating the hepcidin profile in humans following iron supplementation, and few data are available, especially in humans, despite its role as a primary iron absorption and homeostasis regulator. Although several studies have been carried out using iron fortified products, there is limited data on the potential effect of vitamin D on iron metabolism amongst iron deficient women in particular. Therefore, the present study aims to investigate the effect of vitamin D3 supplementation (1500 IU) consumed with iron fortified breakfast cereals on haematological indicators and hepcidin response in iron deficient women.

Description

Recruitment And Sampling Strategy :

Participants will be recruited within the University of Chester, UK only. Emails and posters/leaflets will be used as a medium of advertisement to the target group (staff and students). A total of 62 pre-menopausal women aged between 19 to 40 years old will be included in the study based on criteria described below. Eligibility will be based upon serum ferritin and also vitamin D concentrations at screening before the start of the study. Participants will be required to complete a screening questionnaire which will provide information about participant's health status, drugs/medication/supplement usage, and recent occurrences of illness/trauma/injury. A 6 ml venous blood will be drawn to assess concentrations of plasma ferritin vitamin D, haemoglobin and full blood counts, Participants with plasma ferritin concentrations below 20.0 µg/L and vitamin D concentration below 250 nmol/l will be included in the study. If the levels of haemoglobin are found to be in severe stage of anaemia, the potential participant will be notified and advised to consult their GP (haemoglobin levels < 8.0 g/dL). All eligible participants will be briefed on the study protocol before the beginning of the study, and the eligible participants will be given a Participant Information Sheet (PIS) and asked to provide written informed consent.

An 8 week, double blind, randomised controlled trial will be carried out in Chester, UK. The 8 week intervention period was selected since more than 1 month is appropriate to generally enlarge the erythropoietic marrow and observe changes in red blood cell indices, especially in non-anaemic groups. Most vitamin D studies have used a supplement concentration of 1000 IU and reported no adverse effects in the participants. Some studies have used higher doses of 1600 or 4000 IU with no reported adverse outcomes in the participants.

Participants will be randomly allocated to 2 groups:

1. Fe group (iron fortified breakfast cereals and placebo)

2. Vitamin D group (iron fortified breakfast cereals and vitamin D3).

Each participant will consume 60 grams of iron fortified breakfast cereals containing a total of 9 mg of iron daily for 8 weeks with either vitamin D3 placebo or vitamin D3 (1500 IU) according to their assigned group. The participants will consume the iron fortified breakfast cereals in the morning, with 200 ml of semi-skimmed milk daily for a period of 8 weeks. The participants will consume the vitamin D or placebo in the evening with 200 ml of water. Participants will be asked to maintain their dietary habits and physical activity during the course of study. Participants will also be asked not to donate blood during the course of the study. The remaining supplements will be returned at the final clinic (week 8), and compliance will be estimated.

Participants will be required to attend 3 clinics in total over a period of 8 weeks, and they will be assessed at baseline (Day 0), interim (Week 4) and post intervention (Week 8). Participants will be requested to fast overnight for approximately 8 hours before all clinics. At each clinic, a 30 ml blood sample will be taken and both height (cm) and weight (kg) will be measured. Before the start and the end of the study, participants will be required to keep a 3-day food diary which includes 2 weekdays and 1 weekend day to represent the habitual dietary intake of the participant. Blood samples will be batch analysed at the end of the intervention to assess all biomarkers of iron status and vitamin D metabolism.

Sample size and justification :

Sample size was estimated using iron supplementation data from a study carried out by Scholz-Ahrens et al. (2004) in which a serum ferritin concentration post intervention at 8 weeks (mean ± S.D) of 17.7 ± 11.8 ug/l (Fe fortified milk group) and 10.6 ± 8.1 ug/l (non fortified milk group) was reported. With an effect size of 0.7015447, the total sample size required for each group in the proposed study is 26. Taking into account a 20% drop out rate, the total sample size required is 31 (Power = 0.80). Therefore, the total sample size needed for the whole study is 62. Sample size was estimated using of G Power Software Version 3.1.7.

Statistical Analysis:

All statistical analyses will be conducted with IBM SPSS Statistic Data Editor Software (Version 21). Assuming that the data is normally distributed after performing a Shapiro Wilks normality test, one-way analysis of variance (ANOVA) with repeated measures will be conducted to compare the mean differences for all measured parameters within each group at baseline, interim and post intervention. The changes in the measured parameters between the periods of the study will be analysed using paired t-test. Pearson's correlation test will be performed to investigate the relationship between hepcidin profile and iron status biomarkers. A non-parametric approach will be adopted if the data is not normally distributed for all analyses. Differences will be considered significant with a p value ≤ 0.05.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Conditions

Iron Deficiency

Intervention

Vitamin D3 supplement, Placebo

Location

University of Chester
Chester
Cheshire
United Kingdom
CH1 4BJ

Status

Recruiting

Source

University of Chester

Results (where available)

View Results

Links

Published on BioPortfolio: 2016-03-22T06:23:23-0400

Clinical Trials [2985 Associated Clinical Trials listed on BioPortfolio]

Iron and Vitamin A in School Children

The WHO recommended intermittent iron supplementation as a strategy for prevention of anemia and iron deficiency among school age children. Several aspects of cognitive development, co-sup...

Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C

Iron deficiency is still the most common and widespread nutritional disorder in the world according to WHO. In a recent iron absorption study in adult women with low iron stores in our la...

Hepatitis c and Vitamin D and Iron Status

HCV is associated with vitamin D deficiency. Iron overload is frequently occurred in chronic hepatitis C patients; more than one third of HCV positive patients have elevated serum iron, fe...

Effect of Ascorbic Acid Supplementation in Pregnancy on Anemia (AAA)

A. Anemia is a common problem affecting pregnancy and can result in profound consequences to both the mother and the growing fetus. Current treatment usually includes administration of ora...

How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?

Iron deficiency (ID) affects ~30% of female athletes, and its consequences are highly relevant to athletic performance. Poor iron (Fe) uptake remains a major factor in the development of I...

PubMed Articles [5267 Associated PubMed Articles listed on BioPortfolio]

Impact of vitamin D supplementation model on the circulating levels of 25 (OH) D in Algerian children aged 1-23 months.

Vitamin D deficiency is a public health problem around the world. In Algeria, the nutritional situation is still subject to uncertainties. In order to evaluate the vitamin D status and to know the imp...

Trajectory of vitamin D, micronutrient status and childhood growth in exclusively breastfed children.

This study aimed to compare the trajectory of serum 25(OH)D, micronutrient levels, and anthropometric measurements between exclusively breastfed and mixed-fed children. This is a prospective cohort st...

A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHAT-GUT double-blind, randomised, placebo-controlled trial protocol.

Iron deficiency and its associated anaemia (IDA) are the leading forms of micronutrient malnutrition worldwide. Here we describe the rationale and design of the first clinical trial evaluating the eff...

Evidence of an Association Between Vitamin D Deficiency and Preterm Birth and Preeclampsia: A Critical Review.

Vitamin D deficiency has been associated with adverse pregnancy and birth outcomes such as increased risk for preterm birth and preeclampsia. This state of the science review analyzed recently publish...

DEFINITION OF VITAMIN D DEFICIENCY IN SCHOOLCHILDREN: SYSTEMATIC REVIEW WITH META-ANALYSIS.

Vitamin D deficiency is being recognized as a pandemic due to the volume of people affected by the deficiency and the number of illnesses generated or stimulated by the deficiency. There is a lack of ...

Medical and Biotech [MESH] Definitions

A nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. (Cecil Textbook of Medicine, 19th ed, p1181)

A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406)

Iron or iron compounds used in foods or as food. Dietary iron is important in oxygen transport and the synthesis of the iron-porphyrin proteins hemoglobin, myoglobin, cytochromes, and cytochrome oxidase. Insufficient amounts of dietary iron can lead to iron-deficiency anemia.

A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (From Cecil Textbook of Medicine, 19th ed, p848)

A nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (XEROPHTHALMIA). Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. (From Cecil Textbook of Medicine, 19th ed, p1179)

More From BioPortfolio on "A Study to Investigate the Effect of Vitamin D3 Supplementation on Iron Status in Iron Deficient Women"

Quick Search

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Searches Linking to this Trial